Form 4: AdaptHealth Director Diana Nole Acquires 21,346 Shares of Common Stock
Insider Transaction Report
AdaptHealth Corp. Director Diana L. Nole reported the acquisition of 21,346 shares of common stock, increasing her direct beneficial ownership to 33,045 shares.
Summary
- Diana L. Nole, a Director of AdaptHealth Corp. (AHCO), acquired 21,346 shares of common stock.
- The transaction occurred on June 26, 2025, with an acquisition price of $0 per share, typically indicating a grant or award.
- Following this transaction, Diana L. Nole directly beneficially owns a total of 33,045 shares of AdaptHealth Corp. common stock.
- A Power of Attorney was granted by Diana Nole on February 19, 2025, appointing Richard Rew and Shannone Raybon as attorneys-in-fact to prepare and file SEC reports on her behalf.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive due to a director acquiring shares, which can be interpreted as a sign of confidence in the company. However, as a routine insider transaction, it does not significantly alter the overall sentiment.
Positives
- The acquisition of shares by a director, especially at a $0 price, often signifies compensation or a long-term incentive, aligning management's interests with shareholders.
- An increase in insider ownership can be viewed as a positive signal of confidence in the company's future prospects.
Risks
- The document itself does not detail specific risks related to the company's operations or financial health; it is a report of insider stock ownership changes.
Future Outlook
This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic outlook; it solely reports an insider's stock transaction.
Industry Context
This insider transaction is specific to AdaptHealth Corp. and does not directly reflect broader industry trends. However, insider buying can sometimes be a micro-level indicator of confidence within a specific sector.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Authorization of Agent | Diana Nole granted a Power of Attorney to Richard Rew and Shannone Raybon to handle her SEC filings (Forms 3, 4, 5, Schedules 13D, 13G, and Forms 144) under Section 13 or 16 of the Exchange Act or Rule 144. | 02/19/2025 | This is a standard administrative measure to facilitate timely and compliant SEC filings for insiders, ensuring adherence to regulatory requirements without indicating a change in corporate governance structure or policy. |
Related Party Transactions
- The acquisition of 21,346 shares at a $0 price by a director is typically a grant or award, which is a common form of compensation and a related-party transaction between the company and its director.
Stakeholder Impact
- Shareholders may view the director's acquisition of shares as a positive signal, indicating management's alignment with shareholder interests and confidence in the company's future.
Next Steps
- Diana L. Nole will continue to be subject to Section 16 reporting obligations for her holdings and transactions in AdaptHealth Corp. securities.
Key Dates
| Date | Description |
|---|---|
| 02/19/2025 | Date Diana Nole executed the Power of Attorney appointing Richard Rew and Shannone Raybon. |
| 06/26/2025 | Date of the reported transaction where Diana L. Nole acquired 21,346 shares of common stock. |
| 06/30/2025 | Date the Form 4 was signed by the attorney-in-fact for Diana L. Nole. |
Keywords
AdaptHealth, AHCO, Form 4, Insider Transaction, Director, Stock Acquisition, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.